These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 1262738)

  • 1. Pap smears in primary medical office practice: a review and reevaluation.
    Burdette JA
    J Ky Med Assoc; 1976 Apr; 74(4):177-9. PubMed ID: 1262738
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary care of elderly women: is Pap smear screening necessary?
    Mandelblatt JS; Hammond DB
    Mt Sinai J Med; 1985 Apr; 52(4):284-90. PubMed ID: 3873607
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving preventive care for women: impact of a performance improvement program in a family practice office.
    Gill JM; McClellan SA
    Del Med J; 1998 Jan; 70(1):11-6. PubMed ID: 9489221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
    Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
    Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women and preventive health care: an exploratory study of the use of Pap smears in a potentially high-risk Appalachian population.
    Fisher S; Page AL
    Women Health; 1986; 11(3-4):83-99. PubMed ID: 3564508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and fears among Chilean women with regard to the Papanicolaou test.
    Lamadrid Alvarez S
    Bull Pan Am Health Organ; 1996 Dec; 30(4):354-61. PubMed ID: 9041747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organizational systems used by California capitated medical groups and independent practice associations to increase cancer screening.
    Malin JL; Kahn K; Dulai G; Farmer MM; Rideout J; Simon LP; Ganz PA
    Cancer; 2000 Jun; 88(12):2824-31. PubMed ID: 10870067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demographic, psychosocial, and medical correlates of Pap testing: a literature review.
    Norman SA; Talbott EO; Kuller LH; Krampe BR; Stolley PD
    Am J Prev Med; 1991; 7(4):219-26. PubMed ID: 1756058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in ambulatory care with patient age: is geriatric care qualitatively different?
    Sloane PD
    Fam Med; 1991 Jan; 23(1):40-3. PubMed ID: 2001780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Papanicolaou smear as a sentinel screening test for health screening in women.
    Hueston WJ; Stiles MA
    Arch Intern Med; 1994 Jul; 154(13):1473-7. PubMed ID: 8018002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for cervical and breast cancer--southeastern Kentucky.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 36(52):845-9. PubMed ID: 3122000
    [No Abstract]   [Full Text] [Related]  

  • 12. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas.
    Holland-Barkis P; Forjuoh SN; Couchman GR; Capen C; Rascoe TG; Reis MD
    Prev Med; 2006 Feb; 42(2):140-5. PubMed ID: 16290022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of cervical smears in women harbouring biopsy proven SIL.
    Grabowska H; Nordesjö LO; Matuszkiewicz L
    Pol J Pathol; 1998; 49(3):159-63. PubMed ID: 9810175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pap smear screening and invasive cervical cancer.
    Brown RK; Barker WH
    J Fam Pract; 1982 Nov; 15(5):875-9. PubMed ID: 7130915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaginal cytological smears--experiences from general practitioners in Nordland].
    Teigland G; Lund E
    Tidsskr Nor Laegeforen; 1991 Oct; 111(24):2946-8. PubMed ID: 1948897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L; Jacob S; Hubbard E
    Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pap smear screening in family physicians' offices in a rural area with a high cervical cancer rate.
    Oleszkowicz KL; Kresch GM; Painter JT
    Fam Med; 1994; 26(10):648-50. PubMed ID: 7859958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of vaginal spermatozoa as assessed by routine cervicovaginal (Pap) smears.
    Randall B
    J Forensic Sci; 1987 May; 32(3):678-83. PubMed ID: 3598516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening among elderly urban women in a primary care setting.
    Wong QC; Collins R; Kalkstein K; Roth A; Gintautas J
    Proc West Pharmacol Soc; 2005; 48():154-6. PubMed ID: 16416686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.